Insulet Corp (PODD)
241.37
+3.80
(+1.60%)
USD |
NASDAQ |
Nov 05, 16:00
242.27
+0.90
(+0.37%)
After-Hours: 18:17
Insulet Cash from Operations (Quarterly): 96.50M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 96.50M |
| March 31, 2024 | 87.60M |
| December 31, 2023 | 45.20M |
| September 30, 2023 | 56.00M |
| June 30, 2023 | 44.00M |
| March 31, 2023 | 0.50M |
| December 31, 2022 | 50.70M |
| September 30, 2022 | 56.70M |
| June 30, 2022 | 25.30M |
| March 31, 2022 | -13.70M |
| December 31, 2021 | -25.50M |
| September 30, 2021 | -25.80M |
| June 30, 2021 | 18.30M |
| March 31, 2021 | -35.10M |
| December 31, 2020 | 17.00M |
| September 30, 2020 | 44.20M |
| June 30, 2020 | 26.40M |
| March 31, 2020 | -3.60M |
| December 31, 2019 | 46.90M |
| September 30, 2019 | 31.10M |
| June 30, 2019 | 13.90M |
| March 31, 2019 | 6.50M |
| December 31, 2018 | 30.44M |
| September 30, 2018 | 15.86M |
| June 30, 2018 | -6.129M |
| Date | Value |
|---|---|
| March 31, 2018 | -4.266M |
| December 31, 2017 | 21.89M |
| September 30, 2017 | 23.28M |
| June 30, 2017 | 17.96M |
| March 31, 2017 | -21.84M |
| December 31, 2016 | 20.07M |
| September 30, 2016 | 2.677M |
| June 30, 2016 | 3.681M |
| March 31, 2016 | -10.52M |
| December 31, 2015 | -18.60M |
| September 30, 2015 | 8.746M |
| June 30, 2015 | 0.785M |
| March 31, 2015 | -3.488M |
| December 31, 2014 | 4.607M |
| September 30, 2014 | 4.822M |
| June 30, 2014 | 0.508M |
| March 31, 2014 | -1.017M |
| December 31, 2013 | -3.518M |
| September 30, 2013 | 3.694M |
| June 30, 2013 | 4.372M |
| March 31, 2013 | -1.20M |
| December 31, 2012 | -5.593M |
| September 30, 2012 | -3.449M |
| June 30, 2012 | -11.11M |
| March 31, 2012 | -8.903M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.10M
Minimum
Mar 2021
96.50M
Maximum
Jun 2024
26.93M
Average
26.40M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| Baxter International Inc | 115.00M |
| Boston Scientific Corp | 1.002B |
| Abbott Laboratories | 2.705B |
| Globus Medical Inc | 54.26M |
| Bioventus Inc | 15.16M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -24.90M |
| Cash from Financing (Quarterly) | -0.90M |
| Free Cash Flow | 182.40M |
| Free Cash Flow Per Share (Quarterly) | 0.9702 |
| Free Cash Flow to Equity (Quarterly) | 75.30M |
| Free Cash Flow to Firm (Quarterly) | 77.87M |
| Free Cash Flow Yield | 0.99% |